(Reuters) – A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by ...

AstraZeneca and GlaxoSmithKline have both been in the news this week. In fact, to some extent, they have been the news this week. AstraZeneca has in many ways been the poster child for the patent ...

WASHINGTON, Feb. 8 (UPI) -- A major study indicates AstraZeneca's neuroprotective agent NXY-059 -- the first one to reach phase 3 -- reduced the amount of disability in patients who had suffered an ...

WASHINGTON, Feb. 2 (UPI) -- AstraZeneca said Thursday that its thyroid-cancer drug Zactima has been granted fast-track review. The company is seeking Food and Drug Administration approval of the drug ...

Astrazeneca, the troubled pharmaceutical company, yesterday withdrew its application for European approval of Iressa, the lung cancer drug it had touted as a potential blockbuster. The drug was ...

STOCKHOLM -- Share prices ended lower on Wednesday, as telecommunications and banking issues floundered and AstraZeneca got a boost from the U.S. Food and Drug Administration. The blue-chip OMX index ...

Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots ...

Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots ...

Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots ...

A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine ...